These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 25546254

  • 1. Lactococcus lactis displayed neuraminidase confers cross protective immunity against influenza A viruses in mice.
    Lei H, Peng X, Zhao D, Ouyang J, Jiao H, Shu H, Ge X.
    Virology; 2015 Feb; 476():189-195. PubMed ID: 25546254
    [Abstract] [Full Text] [Related]

  • 2. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H, Peng X, Jiao H, Zhao D, Ouyang J.
    Microb Cell Fact; 2015 Aug 05; 14():111. PubMed ID: 26242406
    [Abstract] [Full Text] [Related]

  • 3. Cross-protective immunity of the haemagglutinin stalk domain presented on the surface of Lactococcus lactis against divergent influenza viruses in mice.
    Lei H, Gao T, Cen Q.
    Virulence; 2021 Dec 05; 12(1):12-19. PubMed ID: 33372841
    [Abstract] [Full Text] [Related]

  • 4. Protective immunity against influenza H5N1 virus challenge in chickens by oral administration of recombinant Lactococcus lactis expressing neuraminidase.
    Lei H, Peng X, Ouyang J, Zhao D, Jiao H, Shu H, Ge X.
    BMC Vet Res; 2015 Apr 02; 11():85. PubMed ID: 25880824
    [Abstract] [Full Text] [Related]

  • 5. Cross-protection of Lactococcus lactis-displayed HA2 subunit against homologous and heterologous influenza A viruses in mice.
    Lei H, Peng X, Zhao D, Jiao H, Ouyang J.
    Arch Virol; 2015 Dec 02; 160(12):3011-9. PubMed ID: 26358264
    [Abstract] [Full Text] [Related]

  • 6. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ, Gabbard JD, Li Z, Dlugolenski DA, Johnson SK, Tripp RA, He B, Tompkins SM.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931689
    [Abstract] [Full Text] [Related]

  • 7. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.
    J Virol; 2015 Jul 01; 89(14):7224-34. PubMed ID: 25948745
    [Abstract] [Full Text] [Related]

  • 8. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L, Kays SK, Zimmer G, von Messling V.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925654
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
    Lu X, Liu F, Zeng H, Sheu T, Achenbach JE, Veguilla V, Gubareva LV, Garten R, Smith C, Yang H, Stevens J, Xu X, Katz JM, Tumpey TM.
    Virology; 2014 Apr 01; 454-455():169-75. PubMed ID: 24725943
    [Abstract] [Full Text] [Related]

  • 10. [Study on immunogenicity of a recombinant adenovirus vaccine containing neuraminidase gene of H5N1 influenza virus (A/Anhui/1/2005) in mice].
    Ma J, Zhang XG, Li KB, Zhang XM, Wang M, Bai T, Yang L, Xu H, Shu YL, Zeng Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec 01; 23(6):449-51. PubMed ID: 20718353
    [Abstract] [Full Text] [Related]

  • 11. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB, Buonocore L, Vogel L, Nachbagauer R, Krammer F, Rose JK.
    J Virol; 2015 Mar 01; 89(5):2820-30. PubMed ID: 25540378
    [Abstract] [Full Text] [Related]

  • 12. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
    Skarlupka AL, Bebin-Blackwell AG, Sumner SF, Ross TM.
    J Virol; 2021 Aug 10; 95(17):e0075921. PubMed ID: 34160258
    [Abstract] [Full Text] [Related]

  • 13. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Kim KH, Jung YJ, Lee Y, Park BR, Oh J, Lee YN, Kim MC, Jeeva S, Kang SM.
    Virology; 2020 Nov 10; 550():51-60. PubMed ID: 32882637
    [Abstract] [Full Text] [Related]

  • 14. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA, Smolonogina TA, Donina SA, Rudenko LG.
    BMC Res Notes; 2015 Apr 10; 8():136. PubMed ID: 25889924
    [Abstract] [Full Text] [Related]

  • 15. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.
    Wohlbold TJ, Nachbagauer R, Xu H, Tan GS, Hirsh A, Brokstad KA, Cox RJ, Palese P, Krammer F.
    mBio; 2015 Mar 10; 6(2):e02556. PubMed ID: 25759506
    [Abstract] [Full Text] [Related]

  • 16. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
    Wu CY, Yeh YC, Chan JT, Yang YC, Yang JR, Liu MT, Wu HS, Hsiao PW.
    PLoS One; 2012 Mar 10; 7(8):e42363. PubMed ID: 22879951
    [Abstract] [Full Text] [Related]

  • 17. Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection.
    Kang HJ, Chu KB, Yoon KW, Eom GD, Mao J, Kim MJ, Lee SH, Moon EK, Quan FS.
    Viruses; 2022 Feb 18; 14(2):. PubMed ID: 35216022
    [Abstract] [Full Text] [Related]

  • 18. A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model.
    Strohmeier S, Amanat F, Zhu X, McMahon M, Deming ME, Pasetti MF, Neuzil KM, Wilson IA, Krammer F.
    mBio; 2021 Dec 21; 12(6):e0224121. PubMed ID: 34809451
    [Abstract] [Full Text] [Related]

  • 19. Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.
    Quan FS, Kim MC, Lee BJ, Song JM, Compans RW, Kang SM.
    Virology; 2012 Sep 01; 430(2):127-35. PubMed ID: 22658901
    [Abstract] [Full Text] [Related]

  • 20. Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.
    Zheng A, Sun W, Xiong X, Freyn AW, Peukes J, Strohmeier S, Nachbagauer R, Briggs JAG, Krammer F, Palese P.
    J Virol; 2020 Jul 30; 94(16):. PubMed ID: 32493826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.